Than, Uyen Thi Trang
Nguyen, Liem Thanh
Nguyen, Phuong Hoang
Nguyen, Xuan-Hung
Trinh, Dong Phuong
Hoang, Diem Huong
Nguyen, Phuong Anh Thi
Dang, Van Duc
Clinical trials referenced in this document:
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Documents that mention this clinical trial
Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy
https://doi.org/10.1038/s41598-023-49902-8
Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida
https://doi.org/10.1186/s13287-023-03349-w
Funding for this research was provided by:
Vinmec (ISC.19.11)
Article History
Received: 29 August 2023
Accepted: 13 December 2023
First Online: 18 December 2023
Competing interests
: The authors declare no competing interests.